Hiromi Tazawa is the CEO of SRD Holdings Co., Ltd
The representative director of SRD Co., Ltd ＆ Himawari Pharmaceutical Company
Representative of Clinical service in China （CSIA) network and Strategic Management and Operation Network Association for Clinical Study （SMONA）
Hiromi Tazawa started being involed in the clinical development of new drugs and generic drugs for approximately 12 years in a pharmaceutical company after received M.D. （Biochemistry）
Then he dedicated himself , in order to widely contribute to the development of the pharmaceutical industry, to the foundation and management of SRD Co., Ltd（CRO）, Medical System Research Corp. （SMO）, Himawari Pharmaceutical Company and Medplus1（SMO in Vietnam）, and M&A of SRD Biology Center Co., Ltd. (CRO specialized in Non-clinical study ) and SRD staff Co.,Ltd. （Dispatching company specialized in medical and clinical research field）